Document Detail


Cardiac amyloidosis: shifting our impressions to hopeful.
MedLine Citation:
PMID:  16928339     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiac amyloidosis is a well-known but clinically rare cause of heart failure that has historically been associated with a poor prognosis. Cardiac amyloidosis involves fibril formation from one of several underlying conditions, and the course of illness and prognosis varies among these conditions. Evolving treatment strategies for patients with primary systemic amyloidosis have given this subset of cardiac amyloidosis patients a cause for hope. The identification and appropriate referral of patients in whom this condition is suspected will help to improve the likelihood of successful therapy and long-term survival.
Authors:
Douglas B Sawyer; Martha Skinner
Related Documents :
368669 - Treatment of patients with neurological deficits associated with cerebral vasospasm by ...
13561109 - Cardiac operations under direct vision; experience with extracoporeal oxygenation of th...
8156179 - Analysis of precordial movements.
7182949 - Time-domain remarks on the cycle-to-cycle variability in some quantities measured on th...
9397309 - Clinical significance of the urinary oxygen tension in patients with ischemic heart dis...
18838359 - Exploring time series retrieved from cardiac implantable devices for optimizing patient...
11708999 - Hearing impairment is common in various phenotypes of the mitochondrial dna a3243g muta...
16116529 - Clinical evaluation of the use of the m2a patency capsule system before a capsule endos...
19776529 - Serum amyloid-a rather than c-reactive protein is a better predictor of mortality in he...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current heart failure reports     Volume:  3     ISSN:  1546-9530     ISO Abbreviation:  Curr Heart Fail Rep     Publication Date:  2006 Jun 
Date Detail:
Created Date:  2006-08-24     Completed Date:  2006-10-31     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101196487     Medline TA:  Curr Heart Fail Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  64-71     Citation Subset:  IM    
Affiliation:
Amyloid Treatment and Research Program, Boston University School of Medicine, 715 Albany Street, K5, Boston, MA 02118, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Amyloidosis / complications*,  diagnosis,  drug therapy
Cardiomyopathies / complications*,  diagnosis,  drug therapy
Cardiovascular Agents / therapeutic use
Clinical Trials as Topic
Heart Failure / etiology
Humans
Prognosis
Chemical
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Rheumatoid arthritis and the heart.
Next Document:  Beta-blocker use in decompensated heart failure.